Compare ABVX & STN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ABVX | STN |
|---|---|---|
| Founded | 2013 | 1954 |
| Country | France | Canada |
| Employees | 67 | N/A |
| Industry | | Military/Government/Technical |
| Sector | | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 10.5B | 10.3B |
| IPO Year | N/A | 2005 |
| Metric | ABVX | STN |
|---|---|---|
| Price | $122.74 | $89.39 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 12 | 1 |
| Target Price | $128.42 | ★ $175.00 |
| AVG Volume (30 Days) | ★ 742.2K | 244.9K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | ★ 0.73% |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $10.95 |
| Revenue Next Year | $0.22 | $6.55 |
| P/E Ratio | ★ N/A | $28.96 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $4.77 | $77.07 |
| 52 Week High | $148.83 | $114.52 |
| Indicator | ABVX | STN |
|---|---|---|
| Relative Strength Index (RSI) | 54.76 | 43.02 |
| Support Level | $106.37 | $85.10 |
| Resistance Level | $131.27 | $96.29 |
| Average True Range (ATR) | 5.18 | 2.96 |
| MACD | 0.22 | -0.03 |
| Stochastic Oscillator | 78.89 | 27.22 |
Abivax SA is a France-based clinical-stage biotechnology company focused on developing therapeutics that harness the body's natural regulatory mechanisms to stabilize the immune response in patients with chronic inflammatory diseases. Company is evaluating its drug candidate, obefazimod, in Phase 3 clinical trials for the treatment of adults with moderately to severely active ulcerative colitis. Its initial focus is on inflammatory bowel diseases, chronic conditions involving inflammation of the gastrointestinal tract, of which the two common forms are UC and CD.
Stantec Inc is a sustainable engineering, architecture, and environmental consulting company. It offers services through the following business operating units; Environmental Services, Infrastructure, Water, Buildings, and Energy & Resources. Maximum revenue is derived from its Infrastructure business unit, which is engaged in evaluating, planning, and designing infrastructure solutions for transportation, community development, and urban spaces. The company's reportable segments are the United States, which derives maximum revenue, Canada, and Global. These segments provide consulting in engineering, architecture, interior design, landscape architecture, surveying, environmental sciences, project management, and project economics services in the area of infrastructure and facilities.